(1)
Cardiovascular Adverse Event Risk in Rheumatoid Arthritis Patients Treated With JAK Inhibitor Tofacitinib Versus TNF Inhibitors: A Systematic Review, Meta Analysis, and Meta Regression. JIMKI 2025, 4. https://doi.org/10.53366/jimki.vi.949.